Infiniplex
Infiniplex is an Israeli startup company focused on revolutionizing cancer treatment monitoring. Their mission is to make cancer screenings affordable and accessible by using routine blood tests to detect genetic tumor biomarkers. They leverage quantitative Real Time PCR (qPCR) technology with novel primers, designed by a proprietary AI-based system, to identify dozens of mutations in various cancer types within a single test. Their product utilizes cell-free DNA (cfDNA) from blood as a non-invasive biomarker for real-time cancer monitoring, aiming to increase efficiency and specificity in mutation detection. The company addresses the unmet need of late cancer diagnosis and the limitations of current monitoring methods.
Infiniplex
Infiniplex is an Israeli startup company focused on revolutionizing cancer treatment monitoring. Their mission is to make cancer screenings affordable and accessible by using routine blood tests to detect genetic tumor biomarkers. They leverage quantitative Real Time PCR (qPCR) technology with novel primers, designed by a proprietary AI-based system, to identify dozens of mutations in various cancer types within a single test. Their product utilizes cell-free DNA (cfDNA) from blood as a non-invasive biomarker for real-time cancer monitoring, aiming to increase efficiency and specificity in mutation detection. The company addresses the unmet need of late cancer diagnosis and the limitations of current monitoring methods.